Franklin Resources’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.69M Buy
124,192
+30,490
+33% +$911K ﹤0.01% 1661
2025
Q4
$3.58M Buy
93,702
+58,978
+170% +$1.92M ﹤0.01% 1554
2025
Q3
$830K Sell
34,724
-41,787
-55% -$786K ﹤0.01% 2203
2025
Q2
$1.13M Buy
76,511
+23,675
+45% +$392K ﹤0.01% 1936
2025
Q1
$947K Buy
52,836
+16,598
+46% +$337K ﹤0.01% 1982
2024
Q4
$631K Buy
+36,238
New +$641K ﹤0.01% 2186
2023
Q2
Sell
-422,961
Closed -$9.51M 2765
2023
Q1
$9.51M Buy
+422,961
New +$8.99M ﹤0.01% 939
2018
Q1
Sell
-880,450
Closed -$18.6M 1548
2017
Q4
$18.6M Sell
880,450
-158,900
-15% -$3.63M 0.01% 812
2017
Q3
$25.9M Hold
1,039,350
0.01% 724
2017
Q2
$20.2M Hold
1,039,350
0.01% 782
2017
Q1
$19.2M Sell
1,039,350
-40,900
-4% -$800K 0.01% 795
2016
Q4
$20.4M Sell
1,080,250
-23,900
-2% -$489K 0.01% 786
2016
Q3
$24.7M Hold
1,104,150
0.01% 745
2016
Q2
$19.7M Sell
1,104,150
-163,800
-13% -$2.65M 0.01% 809
2016
Q1
$17.3M Sell
1,267,950
-246,500
-16% -$3.74M 0.01% 842
2015
Q4
$29.2M Sell
1,514,450
-42,700
-3% -$853K 0.01% 724
2015
Q3
$31.5M Buy
1,557,150
+88,900
+6% +$2.63M 0.02% 712
2015
Q2
$48.7M Buy
1,468,250
+257,800
+21% +$7.06M 0.02% 618
2015
Q1
$29M Buy
+1,210,450
New +$18.5M 0.01% 795

Other funds holding TVTX

Franklin Resources's TVTX Position: Q1 2026 in Review

Franklin Resources increased its Travere Therapeutics (TVTX) stake by 33% in Q1 2026, buying an estimated $911K and bringing the position to 124,192 shares worth $3.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1661.

Franklin Resources first reported a position in TVTX in Q1 2015 and has held it in 19 quarters since. The position peaked at $48.7M in Q2 2015. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Franklin Resources held 124,192 shares of Travere Therapeutics worth $3.69M as of Q1 2026.
  • Franklin Resources bought 30,490 Travere Therapeutics shares in Q1 2026, an estimated $911K.
  • Travere Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #1661 holding.
  • Franklin Resources first reported a position in Travere Therapeutics in Q1 2015 and has held it in 19 quarters since.
  • Franklin Resources's Travere Therapeutics position peaked at $48.7M in Q2 2015.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.